STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
35 hedge funds and large institutions have $104M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
35
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$2.67M | |
| 2 | +$242K | |
| 3 | +$174K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$78.3K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.5K |
Top Sellers
| 1 | -$730K | |
| 2 | -$714K | |
| 3 | -$422K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$366K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$308K |